Wolfgang Huber

Group Leader and Senior Scientist
More …

Simone Bell

Simone has a degree in Nutrition Sciences and Home Economics from the Niederrhein University of Applied Sciences, Mönchengladbach. She acts as Senior Project Manager.
More …

Constantin Ahlmann-Eltze

Constantin joined the Huber Group in July 2019 as PhD student and his work focuses on statistical method development for biological data. He received his Master degree in Molecular Biotechnology from the Heidelberg University. During his Master thesis, he worked on the development of statistical tests for label-free mass spectrometry data.

Hosna Baniadam

Hosna is part of Strasbourg Medical School double degree programme and holds an MSc in bioinformatics from Paris-Saclay University. She joined the Huber group in January 2021 for her master’s thesis and focused on statistical method development for clustering single-cell data. Since September 2021 she is a PhD student in the group and will focus on analysing single-cell multi-omics data to study drug response in blood cancers.

Klemens Tümay Capraz

Tümay studied Biotechnology at the University of Natural Resources and Life Sciences (BOKU) in Vienna. For his master thesis he worked on a high-throughput method for protein complex localization assignment at ETH Zurich. In October 2020 he joined the Huber group as a PhD student to work on the development of new statistical and machine-learning methods for the analysis of multi-omics data.

Donnacha Fitzgerald

After completing his pharmacy studies at University College Cork and the Royal College of Surgeons in Ireland, Donnacha joined the Huber group in October 2019 for a joint PhD with the Dietrich group at the National Centre for Tumour Diseases in Heidelberg. His current research focuses on using single-cell multi-omics to understand intra-tumour heterogeneity of drug response in blood cancers.

Daniel Fridljand

Daniel is currently a second-year master student of mathematics at the University of Heidelberg. In October 2021 he joined the Huber group as a research trainee to work on his master thesis. Daniel will analyze single-cell RNA sequencing algorithms. Before he was a research assistant at Heidelberg Institute for Global Health, working with the Division of Primary Care and Population Health at Stanford University.

Holly Giles

Holly graduated from the University of Cambridge with a degree in Natural Sciences. For her thesis, she investigated the within-host diversity of influenza infections using statistical methods. In 2016, she undertook an internship at the Francis Crick Institute, London, during which she investigated potential new methods of influenza surveillance and vaccine research.
More …

Alexander Helmboldt

Alex received his PhD in theoretical particle physics from the University of Heidelberg and the Max Planck Institute for Nuclear Physics before he joined the Huber group as postdoc fellow in February 2020. As a member of the DECODE project, his current research focuses on single-cell analyses and the development of statistical methods for biological data.

Sarah Kaspar

Sarah completed her PhD in Biology at Heidelberg University, where she developed mathematical models for gene expression in bacteria. Her role at EMBL is shared between the Huber group and Bio-IT (Center for Statistical Data Analysis). She will support EMBL’s scientific community in statistical data analysis by providing consulting and courses.

Vladislav Kim

Vlad is a computational biologist and physicist by training. He acts as interim Center for Statistical Data Analysis (CSDA) at EMBL Heidelberg. For his PhD, he was developing image analysis methods for high-content screening and applying machine learning and statistical methods to help advance antibiotic resistance research..

Caroline Lohoff

Caroline is studying Molecular Biosciences with a focus on Systems and Computational Biology at Heidelberg University. In November 2021 she joined the Huber Group as master thesis student. She will characterize the transcriptomic response of chronic lymphocytic leukemia cells upon drug perturbations using statistics and a high-throughput approach.

Thomas Naake

Thomas obtained his PhD in Biochemistry from the University of Potsdam, while conducting research at the Max Planck Institute of Molecular Plant Physiology in Potsdam-Golm. In November 2020 he joined the Huber group as a postdoctoral fellow. As a member of the SMART-CARE project, his research focuses on using proteomics and metabolomics data sets to understand better tumor biology, vulnerabilities, resistance mechanisms, and the recurrence of different cancer types.

Julia Philipp

Julia received her PhD in Molecular, Cell and Developmental Biology from the University of California, Santa Cruz for her work on alternative splicing and translational control in humans and primates. She joined the Huber group as data manager/ data scientist in July 2021. As a member of the DECODE project and the GHGA Team, she works on creating and maintaining research data infrastructure.

Tobias Roider

Tobias is a physician scientist and postdoctoral fellow. In April 2021, he joined a collaborative research project (SIMONA) between the Huber Group at EMBL and the Dietrich Group at the Heidelberg University Hospital. His current research focuses on understanding intratumor heterogeneity within the lymph node niche using multimodal single cell applications.

Thomas Schwarzl

Tom has a PhD in Bioinformatics and Systems Biology from University College Dublin in Ireland. As EIPOD postdoctoral fellow, he is studying novel RNA-binding dynamics of metabolic enzymes. More …

Mike Smith

Mike joined EMBL as part of the de.NBI project where he is working on the development pipelines, workflows and computational approaches for large scale biological experiments. He has a PhD in computational biology from the University of Cambridge, UK.
More …

Harald Vöhringer

Harald studied Molecular Medicine and Molecular Biology at the University of Göttingen and the International Max Planck Research School before earning his PhD in Cancer Genomics at the University of Cambridge and the European Bioinformatics Institute. After completing a short Postdoc in Covid-19 epidemiology, Harald joined the Dietrich (Heidelberg University Hospital) and Huber groups as postdoctoral fellow in July 2021. Harald focuses on the development of methods to analyse single-cell multi-omics data.